Dublin, July 12, 2021 (GLOBE NEWSWIRE) -- The "Global Topical Drug Delivery Market (2021-2026) by Product, Route of Administration, End-user and Geography - Competitive Analysis, Impact of COVID-19, Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Topical Drug Delivery Market is estimated to be worth USD 95.6 Billion in 2021 and is expected to reach USD 124.9 Billion by 2026, growing at a CAGR of 5.5%.
The market is driven by factors such as the increasing prevalence of skin and eye diseases, high incidences of burn injuries, and the increasing prevalence of diabetes. Higher preference for alternative modes of drug delivery is hindering market growth.
Delivery of biologics through the transdermal route and self-administration and home care are some of the opportunities for the market players to grow.
On the other hand, the technical barriers related to skin irritation and permeability and drug failures and product recalls are huge challenges in front of the industry.
Some of the companies covered in this report are Bausch Health Companies Inc., Bayer AG, Bristol-Myers Squibb, Cipla Inc., Crescita Therapeutics Inc., Galderma S.A., Glaxosmithkline, Glenmark Pharmaceuticals, Hisamitsu Pharmaceutical, Johnson & Johnson, Valeant Pharmaceuticals International, Inc., etc.
The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
By Product, the market is classified into Semi-solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products. The semi-solid formulations contributes largest share of the market.
By Route of Administration, the market is classified as Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery and Nasal Drug Delivery. The Dermal Drug Delivery contributes largest share of the market.
By End-user, the market is classified as Homecare Settings, Hospitals & Clinics, Burn Centres and Other Facilities (academic & research institutes and diagnostic centres). The Homecare Settings contributes largest share of the market.
By Geography, APAC is projected to lead the market.
Key Topics Covered:
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.4 Years Considered
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
4 Market Overview
4.2 Market Dynamics
18.104.22.168 High prevalence of skin diseases
22.214.171.124 Rising prevalence of eye diseases
126.96.36.199 High incidence of burn injuries
188.8.131.52 Growing prevalence of diabetes
184.108.40.206 Preference for alternative modes of drug delivery
220.127.116.11 Delivery of biologics through the transdermal route
18.104.22.168 Self-administration and home care
22.214.171.124 Technical barriers related to skin irritation and permeability
126.96.36.199 Drug failures and product recalls
5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6 Global Topical Drug Delivery Market, By Product
6.2 Semi-solid Formulations
6.3 Liquid Formulations
6.4 Solid Formulations
6.5 Transdermal Products
6.5.1 Transdermal Patches
6.5.2 Transdermal Semi-solids
7 Global Topical Drug Delivery Market, By Route of Administration
7.2 Dermal Drug Delivery
7.3 Ophthalmic Drug Delivery
7.4 Rectal Drug Delivery
7.5 Vaginal Drug Delivery
7.6 Nasal Drug Delivery
8 Global Topical Drug Delivery Market, By End User
8.2 Homecare Settings
8.3 Hospitals & Clinics
8.4 Burn Centres
9 Global Topical Drug Delivery Market, By Geography
10 Competitive Landscape
10.1 Competitive Quadrant
10.2 Market Share Analysis
10.3 Competitive Scenario
11 Company Profiles
Absorption Systems LLC
Bausch Health Companies Inc.
Crescita Therapeutics Inc.
Jenssen Global Services
Johnson & Johnso.
Lead Chemicals Co. Inc.
Lohmann Therapie-Systeme AG
MedPharm Group Ltd
Merck & Co.
Pocono Coated Products LLC
Purdue Pharma L.P.
Skinvisible Pharmaceutical. Inc.
Valeant Pharmaceuticals Internationa. Inc.
For more information about this report visit https://www.researchandmarkets.com/r/73qei
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900